This is the authors' abstract. We don't add key points for this paper.
From the Publisher: Screening techniques are very common in biochemistry and biology to find out if new molecules are potential drugs. The huge amounts of new potential drugs are tested in most of the cases in a screening in view of only one special disease or one special function. There is not enough human power or financial resources to test these substances with common screening methods in order to know if they are active or helpful. Virtual screening can help industry to increase their efficiency drastically by estimating the activity of compounds no in an experiment, but with the computer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Böhm et al. (2000) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: